Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture
dc.contributor.author | Fairchild, Craig R. | en_US |
dc.contributor.author | Maybaum, Jonathan | en_US |
dc.contributor.author | Straw, James A. | en_US |
dc.date.accessioned | 2006-09-11T18:22:34Z | |
dc.date.available | 2006-09-11T18:22:34Z | |
dc.date.issued | 1988-07 | en_US |
dc.identifier.citation | Fairchild, Craig R.; Maybaum, Jonathan; Straw, James A.; (1988). "Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture." Cancer Chemotherapy and Pharmacology 22(1): 26-32. <http://hdl.handle.net/2027.42/46918> | en_US |
dc.identifier.issn | 0344-5704 | en_US |
dc.identifier.issn | 1432-0843 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/46918 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3396144&dopt=citation | en_US |
dc.description.abstract | By inhibiting dihydrofolate reductase, methotrexate (MTX) depletes cellular stores of reduced folates, resulting in the inhibition of DNA and RNA synthesis. Inhibition of RNA synthesis arrests cells in the G 1 phase of the cell cycle, preventing these cells from entering S phase and rendering them insensitive to MTX. Because MTX cytotoxicity can be enhanced by concurrent administration of hypoxanthine (HX), we examined the hypothesis that this modulation can allow normal rates of RNA synthesis and cell cycle progression from G 1 to S phase. For L1210 cells exposed to MTX for 12 h or 24 h, the addition of HX enhanced the cytotoxicity of MTX; however, no enhancement was observed with a 6-h exposure. Inhibition of RNA synthesis by MTX was prevented by concurrent administration of HX. The effect of HX on cell cycle progression was first examined using flow cytometry, which indicated that MTX treatment alone or with concurrent HX caused a buildup of cells with aG 1 content of DNA. Because this technique may fail to distinguish between cells in late G 1 phase, the G 1 /S border, or early S, the method of premature chromosome condensation was used to determine cell cycle position based on chromatin morphology. A shift to a higher degree of chromatin decondensation was observed when HX was coadministered with MTX during a 12-h exposure, suggesting progression from G 1 towards S. This correlated with the enhancement of MTX cytotoxicity by HX after 12 h exposure. The results of these studies suggest that HX potentiates MTX cytotoxicity by maintaining RNA synthesis, allowing cells that mightordinarily be arrested in G 1 to progress into the cytotoxic S phase. | en_US |
dc.format.extent | 1318660 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag | en_US |
dc.subject.other | Pharmacology/Toxicology | en_US |
dc.subject.other | Biomedicine | en_US |
dc.subject.other | Cancer Research | en_US |
dc.subject.other | Oncology | en_US |
dc.title | Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Radiology | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Chemical Engineering | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Engineering | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology, Upjohn Center for Clinical Pharmacology, University of Michigan Medical School, 48109, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Department of Pharmacology, The George Washington University Medical Center, 2300 Eye St., N. W., 20037, Washington, DC, USA | en_US |
dc.contributor.affiliationother | Department of Pharmacology, The George Washington University Medical Center, 2300 Eye St., N. W., 20037, Washington, DC, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 3396144 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/46918/1/280_2004_Article_BF00254176.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF00254176 | en_US |
dc.identifier.source | Cancer Chemotherapy and Pharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.